RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
The benefits of early continuous neuromuscular blockade in patients with acute respiratory distress syndrome (ARDS) who are receiving mechanical ventilation remain unclear.
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @ventilacionmeca: Se acabó la infusión continua de relajantes musculares empleados de forma sistemática en SDRA. https://t.co/p3dtkQiG2V
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
¡Que dijo mi mamá que siempre no!, que le regreses el cisatracurio al Sr de la farmacia. 👍🏻😁🤣 https://t.co/6Zmllx9e8H
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
No paralytic then??? #ATS2019
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @intensivecare_c: ROSE trialが発表になりました! 中等症~重症ARDS(PEEP≧8でP/F比<150)には早期に筋弛緩をした方が良いのか?を検証したRCT 筋弛緩群(cisatracurium)とコントロール群で死亡率に有意差なし、という…
RT @gsmartinmd: The #PETALnetwork #ROSEtrial does not support use of paralytics in moderate-severe #ARDS patients, with no outcome benefit…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @ventilacionmeca: Se acabó la infusión continua de relajantes musculares empleados de forma sistemática en SDRA. https://t.co/p3dtkQiG2V
Early Neuromuscular Blockade in ARDS, PETAL, >1000 pts, no difference in mortality | @NEJM https://t.co/qCJQpIdQG9
RT @ventilacionmeca: Se acabó la infusión continua de relajantes musculares empleados de forma sistemática en SDRA. https://t.co/p3dtkQiG2V
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
RT @jswol: Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/S5jPscsf6B /1
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @jswol: Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/S5jPscsf6B /1
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @emeddoc: Very interesting results from the #PETALnetwork #ROSE trial - maybe early NMB use in moderate-severe ARDS has no benefit after…
RT @emeddoc: Very interesting results from the #PETALnetwork #ROSE trial - maybe early NMB use in moderate-severe ARDS has no benefit after…
RT @emeddoc: Very interesting results from the #PETALnetwork #ROSE trial - maybe early NMB use in moderate-severe ARDS has no benefit after…
RT @emeddoc: Very interesting results from the #PETALnetwork #ROSE trial - maybe early NMB use in moderate-severe ARDS has no benefit after…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @ventilacionmeca: Se acabó la infusión continua de relajantes musculares empleados de forma sistemática en SDRA. https://t.co/p3dtkQiG2V
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
#ROSE vs #ACURASYS. Beneficial effect of light sedation over deep sedation and overall impact of fluid restriction negated the apparent benefit of NMB. Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/DX9XFPlLDY
Not a common occurrence in the Neuro ICU, but curious to see if and how practice will change @erin_barreto @pwierusz @Dre_pharmd
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/qvOrSxH4OS
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
RT @ventilacionmeca: Resultados del bloqueo neuromuscular en SDRA. Todos los tratamientos deben ser personalizados https://t.co/apG9Uln0KR
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @MelanieLaine2: And here it is... the moment we’ve all been waiting for 😶 https://t.co/47xkccbOmR
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
ROSE: Early Neuromuscular Blockade in the ARDS may not have any survival compared to use of lighter sedation/no paralysis, in contrary to the ACURASYS study. https://t.co/FS0zgE6HKl
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @gsmartinmd: The #PETALnetwork #ROSEtrial does not support use of paralytics in moderate-severe #ARDS patients, with no outcome benefit…
RT @intensivecare_c: ROSE trialが発表になりました! 中等症~重症ARDS(PEEP≧8でP/F比<150)には早期に筋弛緩をした方が良いのか?を検証したRCT 筋弛緩群(cisatracurium)とコントロール群で死亡率に有意差なし、という…
RT @DrSamuelBrown: Yup. Turns out control groups probably do matter and relentlessly deep sedation isn't good for you. Glad to be freed of…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @gsmartinmd: The #PETALnetwork #ROSEtrial does not support use of paralytics in moderate-severe #ARDS patients, with no outcome benefit…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
@CNC_SATI
RT @gsmartinmd: The #PETALnetwork #ROSEtrial does not support use of paralytics in moderate-severe #ARDS patients, with no outcome benefit…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @ventilacionmeca: Se acabó la infusión continua de relajantes musculares empleados de forma sistemática en SDRA. https://t.co/p3dtkQiG2V
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @ventilacionmeca: Resultados del bloqueo neuromuscular en SDRA. Todos los tratamientos deben ser personalizados https://t.co/apG9Uln0KR
RT @ventilacionmeca: Se acabó la infusión continua de relajantes musculares empleados de forma sistemática en SDRA. https://t.co/p3dtkQiG2V
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM PETAL trial: stopped for futility: the pendulum of science oscillates again ... https://t.co/VnGUBnzdNK
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @JBLascarrou: Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/7LaTusuqsL
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
And here it is... the moment we’ve all been waiting for 😶
RT @intensivecare_c: ROSE trialが発表になりました! 中等症~重症ARDS(PEEP≧8でP/F比<150)には早期に筋弛緩をした方が良いのか?を検証したRCT 筋弛緩群(cisatracurium)とコントロール群で死亡率に有意差なし、という…
RT @mgdrake: Huge congrats to my colleague @bronchoscope for his tireless commitment to his patients and to this study. Could not have bee…
RT @WF_Parker: Important trial, but why wasn’t proning part of the protocol in both arms? Only 15% of participants were proned compared to…
RT @ogi_gajic: Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/dNA9zfLC2F
@CamCritCareEdu Full paper available from https://t.co/eeoV4jJ9MM
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @DDKrutsinger: The ROSE trial conducted by the PETAL network required 268 investigators, coordinators, & staff to enroll 1006 patients.…
RT @emeddoc: Very interesting results from the #PETALnetwork #ROSE trial - maybe early NMB use in moderate-severe ARDS has no benefit after…
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @ventilacionmeca: Resultados del bloqueo neuromuscular en SDRA. Todos los tratamientos deben ser personalizados https://t.co/apG9Uln0KR
mmm. Might make targeting lower tidal volumes slightly more challenging...
RT @VirtueOfNothing: So that’s 1/3 evidence based interventions for ARDS out the window? 🤔 Early Neuromuscular Blockade in the Acute Respir…
Yup. Turns out control groups probably do matter and relentlessly deep sedation isn't good for you. Glad to be freed of some sort of mandate to paralyze pts w ARDS. Is routine proning next to fall to a failure to reproduce?
Lots to say here but an important study that will hopefully drive practice.
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
ROSE trial shows no mortality benefit from early use of NMB in #ARDS Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/iWAD8n3QyJ
So that’s 1/3 evidence based interventions for ARDS out the window? 🤔 Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/E2nM2IOgKS
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @DocMusician: Bloqueo neuromuscular en SIRA, que dijo mi mamá que siempre no :( https://t.co/RhbamyQlXr
RT @CCJournalClub: Hi #medtwitter #FOAMcc #FOAMed! Join us for our 2nd tweet meet on May 26 9 PM central time & May 27 9 PM IST to discuss…